THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Editor says he should've challenged Vioxx study

New England Journal case adds to concerns over drug-firm studies

By Stephen Smith
Globe Staff / December 10, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The executive editor of the New England Journal of Medicine said yesterday that he should have been more aggressive in challenging research on the blockbuster pain pill Vioxx that appeared in the publication five years ago. (Full article: 817 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass